191 related articles for article (PubMed ID: 12150695)
21. When should an insulin sensitizing agent be used in the treatment of polycystic ovary syndrome?
Franks S
Clin Endocrinol (Oxf); 2011 Feb; 74(2):148-51. PubMed ID: 21121941
[TBL] [Abstract][Full Text] [Related]
22. [Polycystic ovary syndrome. New pathophysiological discoveries--therapeutic consequences].
Svendsen PF; Nilas L; Nørgaard K; Madsbad S
Ugeskr Laeger; 2005 Aug; 167(34):3147-51. PubMed ID: 16117910
[TBL] [Abstract][Full Text] [Related]
23. Metformin therapy in the management of polycystic ovary syndrome: endocrine, metabolic and reproductive effects.
Nardo LG; Rai R
Gynecol Endocrinol; 2001 Oct; 15(5):373-80. PubMed ID: 11727360
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance and the long-term consequences of polycystic ovary syndrome.
Bhathena RK
J Obstet Gynaecol; 2011; 31(2):105-10. PubMed ID: 21281021
[TBL] [Abstract][Full Text] [Related]
25. Insulin resistance in polycystic ovarian disease.
Bhatia V
South Med J; 2005 Sep; 98(9):903-10; quiz 911-2, 923. PubMed ID: 16217983
[TBL] [Abstract][Full Text] [Related]
26. Metformin therapy for the reproductive and metabolic consequences of polycystic ovary syndrome.
Sam S; Ehrmann DA
Diabetologia; 2017 Sep; 60(9):1656-1661. PubMed ID: 28770330
[TBL] [Abstract][Full Text] [Related]
27. Effect of flutamide and metformin administered alone or in combination in dieting obese women with polycystic ovary syndrome.
Gambineri A; Pelusi C; Genghini S; Morselli-Labate AM; Cacciari M; Pagotto U; Pasquali R
Clin Endocrinol (Oxf); 2004 Feb; 60(2):241-9. PubMed ID: 14725687
[TBL] [Abstract][Full Text] [Related]
28. Insulin-lowering agents in the management of polycystic ovary syndrome.
De Leo V; la Marca A; Petraglia F
Endocr Rev; 2003 Oct; 24(5):633-67. PubMed ID: 14570747
[TBL] [Abstract][Full Text] [Related]
29. [The use of oral antidiabetic drugs in the treatment of polycystic ovary syndrome].
Tauchert S; Schröder AK; Ortmann O; Diedrich K; Weiss JM
Zentralbl Gynakol; 2003 Dec; 125(12):507-14. PubMed ID: 14755361
[TBL] [Abstract][Full Text] [Related]
30. Metformin in the treatment of polycystic ovary syndrome.
Motta DA
Curr Pharm Des; 2008; 14(21):2121-5. PubMed ID: 18691121
[TBL] [Abstract][Full Text] [Related]
31. The use of insulin sensitising agents in ovulation induction in women with polycystic ovary syndrome.
Fleming R
Hormones (Athens); 2006; 5(3):171-8. PubMed ID: 16950750
[TBL] [Abstract][Full Text] [Related]
32. The effects of metformin on insulin resistance, clomiphene-induced ovulation and pregnancy rates in women with polycystic ovary syndrome.
Sahin Y; Yirmibeş U; Keleştimur F; Aygen E
Eur J Obstet Gynecol Reprod Biol; 2004 Apr; 113(2):214-20. PubMed ID: 15063963
[TBL] [Abstract][Full Text] [Related]
33. [Insulin resistance and polycystic ovary syndrome].
Bernard L; Christin-Maître S; Basille C; Chabbert-Buffet N
Gynecol Obstet Fertil; 2003 Feb; 31(2):109-16. PubMed ID: 12718982
[TBL] [Abstract][Full Text] [Related]
34. The management of insulin resistance in polycystic ovary syndrome.
Teede HJ; Hutchison SK; Zoungas S
Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
[TBL] [Abstract][Full Text] [Related]
35. Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome.
Diamanti-Kandarakis E; Christakou CD; Kandaraki E; Economou FN
Eur J Endocrinol; 2010 Feb; 162(2):193-212. PubMed ID: 19841045
[TBL] [Abstract][Full Text] [Related]
36. Metformin and other insulin sensitizers in polycystic ovary syndrome.
Bhagavath B; Vitek W; Queenan J; Hoeger K
Semin Reprod Med; 2014 Jul; 32(4):323-30. PubMed ID: 24919033
[TBL] [Abstract][Full Text] [Related]
37. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
[TBL] [Abstract][Full Text] [Related]
38. Polycystic ovary syndrome (PCOS) and the accompanying disorders of glucose homeostasis among girls at the time of puberty.
Otto-Buczkowska E; Grzyb K; Jainta N
Pediatr Endocrinol Diabetes Metab; 2018; 24(1):40-44. PubMed ID: 30083660
[TBL] [Abstract][Full Text] [Related]
39. Efficacy and safety of metformin during pregnancy in women with gestational diabetes mellitus or polycystic ovary syndrome: a systematic review.
Lautatzis ME; Goulis DG; Vrontakis M
Metabolism; 2013 Nov; 62(11):1522-34. PubMed ID: 23886298
[TBL] [Abstract][Full Text] [Related]
40. [Insulin resistance in polycystic ovary syndrome].
Schröder AK; Tauchert S; Ortmann O; Diedrich K; Weiss JM
Wien Klin Wochenschr; 2003 Dec; 115(23):812-21. PubMed ID: 14740344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
